The Gender Health Gap: How Long Women Wait for a Diagnosis

The "gender health gap" is not about women's bodies being harder to read. It is about how health systems have been built — which symptoms count as "typical", how quickly a referral happens, and whose bodies the research was done on. Two of the best-documented UK examples make the pattern concrete: how long it takes to diagnose endometriosis, and how often a woman's heart attack is missed.

Behind every figure on this page is a person who was told her pain was normal, her results were reassuring, or her symptoms were "probably stress" — and who turned out to be right all along. The gap is not an abstraction. It is measured in years of pain nobody could name, in appointments that end without an answer, and in the quiet, exhausted decision to stop asking because no one seems to be listening. When a woman finally hears "we've found it", she is often being believed for the first time in years. The numbers below are a record of how long that took, and how much it cost.

Endometriosis: a diagnosis that takes the better part of a decade

The average time from first symptoms to an endometriosis diagnosis in the UK is now 9 years and 4 months — and it is getting longer, not shorter. A condition that affects roughly 1 in 10 women of reproductive age still takes the best part of a decade to name.

Nine years and four months is not a waiting time; it is a chapter of a life. It is long enough to sit school exams, start a career, move cities, or try to build a family — all while managing pain that can flatten a person for days each month, with no explanation to offer an employer, a partner or oneself. Many describe planning their weeks around the nearest bathroom, cancelling on friends who slowly stop inviting them, and lying on bathroom floors waiting for a flare to pass. Because the pain is invisible and cyclical, it is easy for others to file it under "she doesn't cope well" — and easy for the person living it to start believing that too. That self-doubt is one of the quiet injuries of a delayed diagnosis.

Notice, too, that the wait is not the same for everyone. People from ethnically diverse communities wait longest of all, because bias does not act alone — it stacks. When "period pain that comes and goes" meets assumptions about who exaggerates and who is stoic, the gap widens. A goal of one year by 2030 is achievable; the chart simply shows how far every UK nation still is from it.

The delay is not explained by women failing to seek help. Almost half of people with endometriosis — 47% — had visited their GP ten or more times before being diagnosed, and 70% had been five or more times. The bottleneck is in the system: symptoms are normalised as "bad periods", and referral and diagnostic pathways are slow.

Sit with that for a moment. Ten or more visits means a person who kept showing up, kept describing the same pain, kept asking to be taken seriously — the opposite of a patient who ignores her body. Each return trip is a small act of persistence in the face of being told, gently or otherwise, that this is just what being a woman feels like. The people in this figure did everything they were asked to do. The system is what failed to meet them.

The direction of travel is the most damning part. This is not a historic problem being slowly solved; the wait is growing. Every extra month on this trend is another cohort of people carrying pain into their next year of school, work or parenting without a name for it — and, often, without the treatment that a diagnosis would unlock.

Heart attacks: the same event, a different diagnosis

When women have a heart attack, they are 50% more likely than men to be given the wrong initial diagnosis. That finding comes from an analysis of 564,412 heart-attack patients on England and Wales's national heart-attack register (MINAP), led by the University of Leeds and part-funded by the British Heart Foundation.

The mechanism is structural, not biological: clinical guidelines and the "classic" description of a heart attack were largely built around how the condition presents in men, so women's presentations are more often read as something else.

In practice, a wrong first diagnosis means precious hours lost while heart muscle dies — being sent home with reassurance, treated for anxiety or indigestion, or asked to wait when every minute of a heart attack matters. A woman who senses that something is badly wrong, but is told she is fine, is placed in an impossible position: trust the professional in front of her, or trust her own body. The 70% figure above is the price of that mismatch, and it is not spread evenly across the country or across communities — it lands hardest wherever a woman is least likely to be believed.

The human cost

Put the two examples side by side and a shared logic appears. In one, pain is dismissed for years; in the other, a life-threatening emergency is misread in the moment. The common thread is credibility — how readily a woman's account of her own body is accepted as accurate. When that credibility is discounted by default, the delay it produces is not a rounding error. It is missed education, lost jobs, damaged fertility, mental-health strain, and, at the extreme, deaths that a faster and fairer pathway would have prevented.

These costs ripple outward. Partners and children absorb the caring load; employers lose skilled people who quietly step back rather than explain the unexplainable; and the health service itself pays for late-stage disease it could have caught early. A gap that begins as a clinical oversight becomes, over time, a social and economic one — borne overwhelmingly by the women living inside it.

Why the gap exists

Both examples point the same way. Conditions that mainly affect women have been historically under-researched and under-funded; women were under-represented in the trials that shaped today's guidelines; and referral pathways and clinical education still carry a male-default view of what a condition "looks like". The gap is a product of those choices — which means it can be measured, and changed.

None of this is the fault of the women affected, and none of it is fixed by telling them to advocate harder — the people in these figures already advocated for years. What has to change sits upstream of any individual appointment: research budgets that treat women's conditions as niche, textbooks and decision tools written around a default male patient, and referral routes that assume "bad periods" or "stress" before they assume disease. Because these are decisions rather than facts of biology, they can be un-decided. Faster diagnostic pathways, guidelines that describe how conditions present in women, and research that starts by including them are all within reach. The gap was built; it can be dismantled.

These systemic barriers also affect transgender men and non-binary people who need gynaecological or cardiac care, and are frequently compounded for them. Where the underlying data records only "women", we say so.

How to read this data

Every figure above is from a named UK source for the most recent year available and is linked at the point it is used. National definitions and survey methods differ, so figures are indicative of scale rather than precise to the month; each is dated at its source. This is an analysis of published data, not new clinical research. The heart-attack study was published in 2016 using the MINAP register; the endometriosis figures are from Endometriosis UK's diagnosis surveys.

Why we're publishing this

Health Insurance UK is a commercial UK health-insurance resource, not a charity or a campaign. We compiled this evidence because the people and organisations already fighting to close the gender health gap deserve to have the numbers in one clear, citeable place — and because the case for change is stronger when the data is impossible to wave away. We are not here to speak over the women, clinicians and campaigners who have carried this cause for years; we are here to stand with them and hand them a sharper tool.

Everything here is free to cite with attribution to Health Insurance UK. Use it in your submissions, your briefings, your funding bids and your press. For the underlying figures as a spreadsheet, or a chart in your organisation's style, get in touch.